Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Evaluation of kynurenine 3-monooxygenase as target for Huntington's disease therapy advances

Oct. 6, 2011

HIV-1 DNA/MVA-CMDR prime-boost vaccination evaluated in two clinical studies

Oct. 6, 2011

Incozen Therapeutics describes new PI3K-delta inhibitor

Oct. 5, 2011

Novel pan-Aurora kinase inhibitor is active against drug-resistant cancer cells

Oct. 5, 2011

Preclinical and clinical phase I/II data presented on GSK-573719 for COPD

Oct. 5, 2011

BIO-11006 is efficacious in phase IIa trial

Oct. 4, 2011

AstraZeneca presents novel DNA gyrase inhibitors

Oct. 4, 2011

New serotonin 5-HT3 receptor partial agonists developed for irritable bowel syndrome

Oct. 4, 2011

Merck & Co. assesses new agents potentiating beta-lactam antibiotics against MRSA

Oct. 4, 2011

Studies assess 2-year and sustained-release ONO-5334 therapy

Oct. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...